COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 2376: Articles 23751-23760  | Next

The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines
Luban, J., Sattler, R., Muhlberger, E., Graci, J. D., Cao, L., Weetall, M., Trotta, C., Colacino, J. M., Bavari, S., Strambio-De-Castillia, C., Suder, E. L., Wang, Y., Soloveva, V., Cintron-Lue, K., Naryshkin, N. A., Pykett, M., Welch, E. M., O'Keefe, K., Kong, R., Goodwin, E., Jacobson, A., Paessler, S., Peltz, S.
10.1101/2020.08.05.238394 — Posted: 2020-08-05
Analysis of the potential impact of genomic variants in SARS-CoV-2 genomes from India on molecular diagnostic assays
Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Mathew, S., Sivasubbu, S., Scaria, V.
10.1101/2020.08.05.238618 — Posted: 2020-08-05
Identification of SARS-CoV-2 recombinant genomes
VanInsberghe, D., Neish, A. S., Lowen, A. C., Koelle, K.
10.1101/2020.08.05.238386 — Posted: 2020-08-05
Testing for SARS-CoV-2 in care home staff and residents in English care homes: A service evaluation
Smith, E., Aldus, C. F., Brainard, J., Dunham, S., Hunter, P. R., Steel, N., Everden, P.
10.1101/2020.08.04.20165928 — Posted: 2020-08-05
Alveolitis in severe SARS-CoV-2 pneumonia is driven by self-sustaining circuits between infected alveolar macrophages and T cells
Grant, R. A., Morales-Nebreda, L., Markov, N. S., Swaminathan, S., Guzman, E. R., Abbott, D. A., Donnelly, H. K., Donayre, A., Goldberg, I. A., Klug, Z. M., Borkowski, N., Lu, Z., Kihshen, H., Politanska, Y., Sichizya, L., Kang, M., Shilatifard, A., Qi, C., Argento, A. C., Kruser, J. M., Malsin, E. S., Pickens, C. O., Smith, S., Walter, J. M., Pawlowski, A. E., Schneider, D., Nannapaneni, P., Abdala-Valencia, H., Bharat, A., Gottardi, C. J., Budinger, G. S., Misharin, A. A., Singer, B. D., Wunderink, R. G., The NU SCRIPT Study Investigators
10.1101/2020.08.05.238188 — Posted: 2020-08-05 Discussion: Onsite | Offsite
Comparative Evaluation of Three Serologic Assays for the Identification of SARS-CoV-2 Antibodies
Hogan, K. O., Klippel, D., Plapp, F. V., Liesman, R. M.
10.1101/2020.08.04.20167643 — Posted: 2020-08-05
Seroprevalence of COVID-19 in Niger State
Majiya, H., Aliyu-Paiko, M., Balogu, V. T., Musa, D. A., Salihu, I. M., Kawu, A. A., Bashir, I. Y., Sani, A. R., Baba, J., Muhammad, A. T., Jibril, F. L., Bala, E., Obaje, N. G., Aliyu, Y. B., Muhammad, R. G., Mohammed, H., Gimba, U. N., Uthman, A., Liman, H. M., Alhaji, S. A., James, J. K., Makusidi, M. M., Isah, M. D., Abdullahi, I., Ndagi, U., Waziri, B., Bisallah, C. I., Dadi-Mamud, N. J., Ibrahim, K., Adamu, A. K.
10.1101/2020.08.04.20168112 — Posted: 2020-08-05 Discussion: Onsite
Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage
Gupta, S., Singh, R., Paul, P.
10.1101/2020.08.05.237404 — Posted: 2020-08-05
Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein (N protein) and its consequences
Rahman, M. S., Islam, M. R., Ul Alam, A. S. M. R., Islam, I., Hoque, M. N., Akter, S., Rahaman, M. M., Sultana, M., Hossain, M. A.
10.1101/2020.08.05.237339 — Posted: 2020-08-05
Rapid GMP-compliant expansion of SARS-CoV-2-specific T cells from convalescent donors for use as an allogeneic cell therapy for COVID-19
Cooper, R. S., Fraser, A. R., Smith, L., Burgoyne, P., Imlach, S. N., Jarvis, L. M., Zahara, S., Turner, M. L., Campbell, J. D.
10.1101/2020.08.05.237867 — Posted: 2020-08-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).